As SGC progresses, the cancer cells may acquire resistance to anoikis through ANGPTL4-dependent activation of FAK/Src/PI3K-Akt/ERK signalling, leading to the development of peritoneal metastasis. The gene discussed is PTK2; the disease is cancer.